Brenntag's quarterly figures were released, prompting UBS to maintain its 'Buy' rating for the company and set a target price of 80 euros. Despite the adjusted Ebita falling short of consensus estimates by 6 percent, analyst Rory McKenzie believes that the confirmed annual outlook could provide some support for the stock.
However, Brenntag shares have experienced a significant decline, with prices dropping to 55.70 euros, reflecting a decrease of 9.46 percent. The stock has shown considerable volatility, with a year high of 87.12 euros and a year low of 55.24 euros.
Similar downward trends are being reported on various trading venues, including Tradegate and Xetra, with prices around 55.92 euros and 55.70 euros, respectively.